Scientific Reports · 2014 · 31 citations · 17 references
Life SciencesGeneticsMolecular BiologyEpilepsyGenetic EngineeringMolecular NeuroscienceChannelopathiesDna DamageEpilepsy GeneticsGenetic EpilepsiesMolecular NeurogeneticsDisease-causing VariantsDna Double-strand BreaksDouble-strand Dna BreaksDrug ScreeningInduced Pluripotent Stem CellsPoint MutationsSodium Channel GenesTranscription Activator-like Effectors
Human induced pluripotent stem cells (iPSC) can be used to understand the pathological mechanisms of human disease. These cells are a promising source for cell-replacement therapy. However, such studies require genetically defined conditions. Such genetic manipulations can be performed using the novel Transcription Activator-Like Effector Nucleases (TALENs), which generate site-specific double-strand DNA breaks (DSBs) with high efficiency and precision. Combining the TALEN and iPSC methods, we developed two iPS cell lines by generating the point mutation A5768G in the SCN1A gene, which encodes the voltage-gated sodium channel Nav1.1 α subunit. The engineered iPSC maintained pluripotency and successfully differentiated into neurons with normal functional characteristics. The two cell lines differ exclusively at the epilepsy-susceptibility variant. The ability to robustly introduce disease-causing point mutations in normal hiPS cell lines can be used to generate a human cell model for studying epileptic mechanisms and for drug screening.
17
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki et al. · Cell · 2007 · 20.2K citations
Proposal for Revised Classification of Epilepsies and Epileptic Syndromes
Epilepsia · 1989 · 5.4K citations
Medicine, Neurology, Neuroscience +12
Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin
Jacob H. Hanna, Marius Wernig, Styliani Markoulaki et al. · Science · 2007 · 1.5K citations
Life Sciences, Genetics, Hematology +16